claim
Posted by admin
•
September 24, 2026 at 04:00 PM
FDA leadership should measure success by both speed and safety outcomes, publishing annual data on both approval timelines and adverse event rates.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!